CSL Limited Company Profile (ASX:CSL)

About CSL Limited (ASX:CSL)

CSL Limited logoCSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: ASX:CSL
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: A$130.75
  • 200 Day Moving Avg: A$114.65
P/E:
  • Trailing P/E Ratio: 45.96
  • P/E Growth: 1.47
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for CSL Limited (ASX:CSL)

What is CSL Limited's stock symbol?

CSL Limited trades on the ASX under the ticker symbol "CSL."

Who are some of CSL Limited's key competitors?

Analyst Ratings

Consensus Ratings for CSL Limited (ASX:CSL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for CSL Limited (ASX:CSL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for CSL Limited (ASX:CSL)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for CSL Limited (ASX:CSL)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for CSL Limited (ASX:CSL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CSL Limited (ASX:CSL)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for CSL Limited (ASX:CSL)
Latest Headlines for CSL Limited (ASX:CSL)
Source:
DateHeadline
fool.com logo3 growth ideas: Buy, Hold, or Sell? - Motley Fool Australia
www.fool.com.au - May 23 at 3:46 PM
fool.com logoHere are 3 fast-growing healthcare shares on my shopping list - Motley Fool Australia
www.fool.com.au - May 23 at 3:46 PM
finance.yahoo.com logoNew Innovation in the Fight Against Hemophilia Earns CSL Behring the NORD 2017 Industry Innovation Award
finance.yahoo.com - May 19 at 8:29 AM
fool.com logoWhy Sirtex Medical Limited's FOXFIRE trial results disappointed - Motley Fool Australia
www.fool.com.au - May 18 at 10:53 AM
fool.com logoHere are 3 healthcare shares you can buy and hold for a decade
www.fool.com.au - May 17 at 9:38 PM
businesswire.com logoGlobal Blood Plasma Market Report: Industry Analysis & Outlook 2017-2021 Featuring Shire, CSL Limited, Grifols and Octapharma - Research and Markets
www.businesswire.com - May 17 at 4:38 PM
fool.com logoAt $135 per share, is CSL Limited still an opportunity?
www.fool.com.au - May 11 at 10:12 PM
seekingalpha.com logoXencor's (XNCR) CEO Bassil Dahiyat on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:10 AM
prnewswire.com logoXencor Reports First Quarter 2017 Financial Results
www.prnewswire.com - May 9 at 4:29 PM
nasdaq.com logoAustralia Business Conditions & Confidence High: ETFs to Buy
www.nasdaq.com - May 9 at 4:29 PM
bizjournals.com logoH1 Hemophilia B 2017 Pipeline Comprehensive Market Analysis Report at ReportsnReports.com
www.bizjournals.com - May 9 at 8:01 AM
reuters.com logoAustralia shares fall on lower miners and energy stocks; NZ edges up
www.reuters.com - May 5 at 2:43 AM
finance.yahoo.com logoETFs with exposure to CSL Ltd. : May 2, 2017
finance.yahoo.com - May 2 at 4:00 PM
fool.com logoMayne Pharma Group Ltd shares plunge as it warns of tougher ... - Motley Fool Australia
www.fool.com.au - May 1 at 8:20 AM
fool.com logo3 ASX shares I'd buy and never sell - Motley Fool Australia
www.fool.com.au - May 1 at 8:20 AM
fool.com logoAustralia's ASX 200 is BOOMING: Is it too late to buy? - Motley Fool Australia
www.fool.com.au - April 27 at 10:05 PM
prnewswire.com logoWirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card - PR Newswire (press release)
www.prnewswire.com - April 27 at 10:05 PM
finance.yahoo.com logoGlobal Hereditary Angioedema Market: Size, Trends & Forecasts 2017-2021 Featuring Shire, iBio, Pharming Group ... - Yahoo Finance
finance.yahoo.com - April 27 at 10:05 PM
bizjournals.com logoBlood Plasma Market: Global Industry Analysis, Trends, Size, Growth Drivers and 2021 Forecasts Discussed in New Research Report - MarketReportsOnline
www.bizjournals.com - April 27 at 5:04 PM
finance.yahoo.com logoWirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card
finance.yahoo.com - April 25 at 12:01 PM
fool.com logo3 reasons all property buyers should own shares
www.fool.com.au - April 20 at 9:42 PM
finance.yahoo.com logoTherapeutic Goods Administration Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment
finance.yahoo.com - April 19 at 4:30 PM
fool.com logoHow CSL Limited makes most of its money
www.fool.com.au - April 18 at 12:13 PM
finance.yahoo.com logoETFs with exposure to CSL Ltd. : April 17, 2017
finance.yahoo.com - April 17 at 4:16 PM
msn.com logoWhy making big money in the share market is much easier than you think
www.msn.com - April 12 at 9:35 PM
fool.com logoHere are 3 small-cap stars I would buy today
www.fool.com.au - April 12 at 9:35 PM
fool.com logoHere are 3 exciting biotech shares for growth investors
www.fool.com.au - April 10 at 12:08 PM
finance.yahoo.com logoImproving Access to Lifesaving Treatments for Bleeding Disorders in the Developing World
finance.yahoo.com - April 10 at 12:08 PM
fool.com logo3 top healthcare shares for growth investors
www.fool.com.au - April 7 at 9:14 AM
finance.yahoo.com logoETFs with exposure to CSL Ltd. : April 5, 2017
finance.yahoo.com - April 7 at 9:14 AM
fool.com logo2 growth shares to buy instead of CSL Limited
www.fool.com.au - April 3 at 9:57 PM
fool.com logoBuy, hold, sell: Rio Tinto Limited, Fortescue Metals Group Limited and CSL Limited
www.fool.com.au - April 3 at 2:25 AM
fool.com logo3 great ways to globally diversify your portfolio
www.fool.com.au - April 2 at 9:25 PM
finance.yahoo.com logoJeffrey Modell Foundation to Open the First North African Network for Primary Immunodeficiencies
finance.yahoo.com - March 31 at 4:40 PM
fool.com logo3 shares I’d love to buy at lower prices
www.fool.com.au - March 30 at 10:08 PM
finance.yahoo.com logoCSL Behring Awards Grant To Patient Groups To Develop Innovative Ways To Advocate For Patients
finance.yahoo.com - March 29 at 5:00 PM
finance.yahoo.com logo/DISREGARD RELEASE: CSL Behring/
finance.yahoo.com - March 29 at 12:02 PM
fool.com logoCould these be 3 of the ASX’s most undervalued shares right now?
www.fool.com.au - March 23 at 10:07 PM
finance.yahoo.com logoNew England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients
finance.yahoo.com - March 22 at 9:41 PM
reuters.com logoAustralia shares tumble tracking Wall Street; NZ hits 7-week low
www.reuters.com - March 21 at 9:50 PM
fool.com logoGot a spare $5,000? I would invest it in these 3 ASX shares
www.fool.com.au - March 17 at 3:55 AM
fool.com logoAre CSL Limited (ASX:CSL) shares overpriced today?
www.fool.com.au - March 13 at 12:23 PM
reuters.com logoAussie shares end at one-week high; New Zealand up
www.reuters.com - March 10 at 11:48 AM
fool.com logoInvest like Peter Lynch with these 3 ASX stock tips
www.fool.com.au - March 10 at 11:48 AM
finance.yahoo.com logoVaccines Market by Technology, Disease Indication, End User & Type - Forecasts to 2021
finance.yahoo.com - March 9 at 10:06 PM
fool.com logoYour instant 5-share ASX healthcare portfolio
www.fool.com.au - March 9 at 10:06 PM
finance.yahoo.com logoLargest Ever CIDP Clinical Study Completed
finance.yahoo.com - March 1 at 1:24 PM
rttnews.com logoCSL HY Profit Rises
www.rttnews.com - February 16 at 12:28 PM
reuters.com logoBRIEF-CSL Ltd updates on outlook
www.reuters.com - February 16 at 12:28 PM
seekingalpha.com logoIndustry Leaders: Relaxing FDA Standards Will Kill The Pharma Golden Goose
seekingalpha.com - February 16 at 12:28 PM

Social

Social activity is not available for this stock.
This page was last updated on 5/24/2017 by MarketBeat.com Staff